Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 13/01/2014 → 31/01/2015 |
Funding
- Takeda Global R&D Centre (Europe) Ltd: £942,898.00
A Randomized, Double-Blind, Placebo-Controlled, 3-period, Proof of Mechanism, Cross-Over Study of Roflumilast (100 or 250 ug) administered up to Steady State to Evaluate the Effects of Add-on Roflumilast to Second Generation Antipsychotics
- Shergill, Sukhi (Primary Investigator)
- Ffytche, Dominic (Co-Investigator)
- Gilleen, James (Co-Investigator)
- Mehta, Mitul (Co-Investigator)
- Williams, Steven (Co-Investigator)
Project: Research